# Sorafenib in Elderly mRCC

> **NCT01728948** · — · COMPLETED · sponsor: **Bayer** · enrollment: 60 (actual)

## Conditions studied

- Carcinoma, Renal Cell

## Interventions

- **DRUG:** Sorafenib (Nexavar, BAY43-9006)

## Key facts

- **NCT ID:** NCT01728948
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01-06
- **Primary completion:** 2016-01-04
- **Final completion:** 2017-01-16
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-11-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01728948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01728948, "Sorafenib in Elderly mRCC". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01728948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*